Table 1 Patient characteristics according to whether GnRHa was injected.

From: Analysis of the benefit of gonadotropin-releasing hormone agonist treatment in premenopausal women undergoing hematopoietic cell transplantation

Characterics

Treatment group, n = 77(%)

Control group, n = 157(%)

P value

Age(mean ± SD), years

23.83 ± 6.66

24.51 ± 6.79

0.180

Hematologic diseases type

  

0.017

 ALL

25

62

 

 AML

25

68

 

 AA

16

13

 

 MDS

9

8

 

 Other

2

6

 

HLA-matched situation

  

0.599

 HLA-matched

13

31

 

 HLA-haploidentical

64

126

 

Cyclic chemotherapy before HSCT

  

0.002

 Yes

52 (67.53)

134 (85.35)

 

 No

25

23

 

GVHD

  

0.623

 Yes

50

107

 

 No

27

50

 
  1. P value indicates the differences between the two groups.
  2. ALL acute lymphocytic leukemia, AML acute myelogenous leukemia, AA aplastic anemia, MDS myelodysplastic syndrome, GVHD graft versus host disease.
Back to article page